Literature DB >> 18373208

Fragment-based and classical quantitative structure-activity relationships for a series of hydrazides as antituberculosis agents.

Carolina H Andrade1, Livia de B Salum, Marcelo S Castilho, Kerly F M Pasqualoto, Elizabeth I Ferreira, Adriano D Andricopulo.   

Abstract

Worldwide, tuberculosis (TB) is the leading cause of death among curable infectious diseases. Multidrug-resistant Mycobacterium tuberculosis is an emerging problem of great importance to public health, and there is an urgent need for new anti-TB drugs. In the present work, classical 2D quantitative structure-activity relationships (QSAR) and hologram QSAR (HQSAR) studies were performed on a training set of 91 isoniazid derivatives. Significant statistical models (classical QSAR, q (2) = 0.68 and r (2) = 0.72; HQSAR, q (2) = 0.63 and r (2) = 0.86) were obtained, indicating their consistency for untested compounds. The models were then used to evaluate an external test set containing 24 compounds which were not included in the training set, and the predicted values were in good agreement with the experimental results (HQSAR, r(2)(pred) = 0.87; classical QSAR, r(2)(pred) = 0.75).

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18373208     DOI: 10.1007/s11030-008-9074-z

Source DB:  PubMed          Journal:  Mol Divers        ISSN: 1381-1991            Impact factor:   2.943


  24 in total

1.  Structure-activity relationships for a collection of structurally diverse inhibitors of purine nucleoside phosphorylase.

Authors:  A D Andricopulo; R A Yunes
Journal:  Chem Pharm Bull (Tokyo)       Date:  2001-01       Impact factor: 1.645

2.  Chemotherapy of experimental tuberculosis. VII. Heterocyclic acid hydrazides and derivatives.

Authors:  J BERNSTEIN; W P JAMBOR; W A LOTT; F PANSY; B A STEINBERG; H L YALE
Journal:  Am Rev Tuberc       Date:  1953-03

3.  Chemotherapy of experimental tuberculosis. VI. Derivatives of isoniazid.

Authors:  J BERNSTEIN; W P JAMBOR; W A LOTT; F PANSY; B A STEINBERG; H L YALE
Journal:  Am Rev Tuberc       Date:  1953-03

4.  Virtual screening for aryl hydrocarbon receptor binding prediction.

Authors:  Elena Lo Piparo; Konrad Koehler; Antonio Chana; Emilio Benfenati
Journal:  J Med Chem       Date:  2006-09-21       Impact factor: 7.446

Review 5.  Virtual screening and its integration with modern drug design technologies.

Authors:  Rafael V C Guido; Glaucius Oliva; Adriano D Andricopulo
Journal:  Curr Med Chem       Date:  2008       Impact factor: 4.530

Review 6.  Recent advances in the diagnosis and management of tuberculosis.

Authors:  Jennifer J Furin; John L Johnson
Journal:  Curr Opin Pulm Med       Date:  2005-05       Impact factor: 3.155

7.  Evaluation of quantitative structure-activity relationship methods for large-scale prediction of chemicals binding to the estrogen receptor.

Authors:  W Tong; D R Lowis; R Perkins; Y Chen; W J Welsh; D W Goddette; T W Heritage; D M Sheehan
Journal:  J Chem Inf Comput Sci       Date:  1998 Jul-Aug

8.  Hologram quantitative structure-activity relationships for a series of farnesoid X receptor activators.

Authors:  Kathia M Honorio; Richard C Garratt; Adriano D Andricopulo
Journal:  Bioorg Med Chem Lett       Date:  2005-06-15       Impact factor: 2.823

9.  Structural basis for selective inhibition of trypanosomatid glyceraldehyde-3-phosphate dehydrogenase: molecular docking and 3D QSAR studies.

Authors:  Rafael V C Guido; Glaucius Oliva; Carlos A Montanari; Adriano D Andricopulo
Journal:  J Chem Inf Model       Date:  2008-02-28       Impact factor: 4.956

10.  Structural and chemical basis for enhanced affinity and potency for a large series of estrogen receptor ligands: 2D and 3D QSAR studies.

Authors:  Lívia de B Salum; Igor Polikarpov; Adriano D Andricopulo
Journal:  J Mol Graph Model       Date:  2007-02-08       Impact factor: 2.518

View more
  8 in total

Review 1.  Fragment-based QSAR: perspectives in drug design.

Authors:  Lívia B Salum; Adriano D Andricopulo
Journal:  Mol Divers       Date:  2009-01-31       Impact factor: 2.943

2.  Predictive QSAR workflow for the in silico identification and screening of novel HDAC inhibitors.

Authors:  Georgia Melagraki; Antreas Afantitis; Haralambos Sarimveis; Panayiotis A Koutentis; George Kollias; Olga Igglessi-Markopoulou
Journal:  Mol Divers       Date:  2009-02-10       Impact factor: 2.943

Review 3.  Computational databases, pathway and cheminformatics tools for tuberculosis drug discovery.

Authors:  Sean Ekins; Joel S Freundlich; Inhee Choi; Malabika Sarker; Carolyn Talcott
Journal:  Trends Microbiol       Date:  2010-12-02       Impact factor: 17.079

4.  QSAR-driven design, synthesis and discovery of potent chalcone derivatives with antitubercular activity.

Authors:  Marcelo N Gomes; Rodolpho C Braga; Edyta M Grzelak; Bruno J Neves; Eugene Muratov; Rui Ma; Larry L Klein; Sanghyun Cho; Guilherme R Oliveira; Scott G Franzblau; Carolina Horta Andrade
Journal:  Eur J Med Chem       Date:  2017-05-10       Impact factor: 6.514

5.  Elucidating the structural basis of diphenyl ether derivatives as highly potent enoyl-ACP reductase inhibitors through molecular dynamics simulations and 3D-QSAR study.

Authors:  Pharit Kamsri; Auradee Punkvang; Patchareenart Saparpakorn; Supa Hannongbua; Stephan Irle; Pornpan Pungpo
Journal:  J Mol Model       Date:  2014-06-17       Impact factor: 1.810

Review 6.  Recent advances in fragment-based QSAR and multi-dimensional QSAR methods.

Authors:  Kyaw Zeyar Myint; Xiang-Qun Xie
Journal:  Int J Mol Sci       Date:  2010-10-08       Impact factor: 5.923

7.  In silico repositioning-chemogenomics strategy identifies new drugs with potential activity against multiple life stages of Schistosoma mansoni.

Authors:  Bruno J Neves; Rodolpho C Braga; José C B Bezerra; Pedro V L Cravo; Carolina H Andrade
Journal:  PLoS Negl Trop Dis       Date:  2015-01-08

8.  Elucidating drug-enzyme interactions and their structural basis for improving the affinity and potency of isoniazid and its derivatives based on computer modeling approaches.

Authors:  Auradee Punkvang; Patchreenart Saparpakorn; Supa Hannongbua; Peter Wolschann; Pornpan Pungpo
Journal:  Molecules       Date:  2010-04-16       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.